adriforant (ZPL 3893787) - Novartis
Novartis Second Quarter and Half Year 2020 (Novartis) - Jul 22, 2020 - "Project discontinued for ZPL389 in atopic dermatitis." 
Discontinued Atopic Dermatitis • Dermatology
https://www.novartis.com/sites/www.novartis.com/files/2020-07-interim-financial-report-en.pdf
 
Jul 22, 2020
 
 
33d1f9e2-4dfc-4735-9161-f761ccf7ad9d.jpg